Bio-Rad Laboratories, Inc.Class A

BIONYSE • USD
362.17 USD
↗ 1.67 (0.46%)🟢LIVE (AS OF 02:14 PM EDT)
🟢Market: OPEN

Bio-Rad Laboratories, Inc.Class A (BIO) is currently trading at $362.17. Our models show a "Sell" technical signal alongside a "Neutral" fundamental rating. This is driven by a robust Altman Z-Score and a bullish Golden Cross on the moving averages. On valuation, BIO trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Oct 21, 2026.

Open?$359.83
High?$367.89
Low?$359.83
Prev. Close?$360.50
Volume?112.9K
Avg. Volume?267.7K
VWAP?$364.38
Rel. Volume?0.42x
Bid / Ask
Bid?$361.73 × 40
Ask?$362.58 × 120
Spread?$0.85
Midpoint?$362.16
Valuation & Ratios
Market Cap?9.6B
Shares Out?21.7M
Float?18.5M
Float %?85.2%
P/E Ratio?43.34
P/B Ratio?1.34
EPS?$8.32
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Employees
7.5K
Market Cap
9.6B
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Listed
1980-02-29
Address
1000 ALFRED NOBEL DRIVE
HERCULES, CA 94547
Phone: (510) 724-7000
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
85
Momentum?
48
Short Sent.?
59
Piotroski F-Score?5/9Mixed
Altman Z-Score?3.54Safe
Confidence?71%Moderate
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?6.40%Elevated
Short Interest?1.2M
Days to Cover?4.3
Free Float18.5M
Avg Daily Volume276.9K
Settlement Date2026-09-30
Financial Health
Current Ratio?3.14Strong
Quick Ratio?2.33Strong
Cash Ratio?0.54Adequate
Debt/Equity?0.17Low
ValuationFAIRLY VALUEDvs 10 peers + S&P 500
Score
61/100
P/E?
Peers
55
S&P
16
43.3PRICEY▾
P/B?
Peers
100
S&P
91
1.34CHEAP▾
P/S?
Peers
91
S&P
41
3.72FAIR▾
P/FCF?
Peers
91
S&P
34
27.3FAIR▾
EV/EBITDA?
Peers
27
S&P
3
45.7HIGH▾
EV/Sales?
Peers
91
S&P
47
3.99FAIR▾
Returns & Efficiency
ROE?
Peers
18
S&P
18
3.1%WEAK▾
ROA?
Peers
27
S&P
21
2.2%WEAK▾
Cash Flow & Enterprise
FCF?$353.1M
Enterprise Value?$10.3B
Fundamentals ratios updated end of day